7月14日，百特国际盘中下跌5.14%，报21.43美元/股，成交额1934.39万美元。
消息面上，高盛当日将百特国际目标价从19美元上调至21美元，但维持中性评级，目标价仍低于此前交易价格，暗示估值上行空间有限。同时，医疗保健设备板块整体遭遇抛压，行业内主要个股普跌：史赛克跌5.99%、GE医疗跌5.70%、直觉外科跌3.93%、波士顿科学跌3.83%、雅培跌2.60%。板块系统性下行叠加机构审慎评级，共同压制百特国际走势。
百特国际有限公司提供广泛的基本医疗保健产品，包括无菌静脉溶液、输液系统和设备、肠外营养疗法、手术止血剂和密封剂产品等。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.